01 Jun 2023
Statement from the Doherty Institute
The Doherty Institute frequently evaluates the antiviral properties of products under paid contracts with commercial entities.
Recent work, commissioned by the company Australian Garlic Producers (AGP), involved in-vitro testing only of a range of garlic extracts to investigate potential antiviral activity against two viruses.
The findings of this lab-based study, released by AGP, do not show medical treatment application. Stringent clinical trials would need to be conducted to determine if these findings translate from test tubes to humans.